ClinicalTrials.Veeva

Menu

Cryotherapy of Sclerotomy Sites for Prevention of Late Postvitrectomy Diabetic Hemorrhage

S

Shahid Beheshti University of Medical Sciences

Status

Completed

Conditions

Late Postvitrectomy Diabetic Hemorrhage.

Treatments

Procedure: Cryotherapy

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Late vitreous hemorrhage in postvitrectomized diabetic eyes may be due to fibrovascular tuft formation in sclerotomy sites. Cryotherapy of sclerotomy sites may prevent bleeding by regressing the fibrovascular tuft. This study will detect the safety and efficacy of cryotherapy of sclerotomy sites for prevention of late vitreous hemorrhage in vitrectomized diabetic eyes.

Enrollment

112 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diabetic retinopathy cases undergoing vitrectomy

Exclusion criteria

  • History of deep vitrectomy or cataract surgery
  • Renal failure
  • Silicone oil injection during surgery
  • Early rebleeding
  • History of antithrombotic drugs usage

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

112 participants in 2 patient groups, including a placebo group

1
Experimental group
Description:
Cryotherapy
Treatment:
Procedure: Cryotherapy
2
Placebo Comparator group
Treatment:
Procedure: Cryotherapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems